Population pharmacokinetics with a very small sample size

Drug Metabolism and Drug Interactions

Volumn 24, Issue 2-4, 2009, Pages 259-274

  Mahmood, Iftekhar ^a   Duan, John ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Clearance; Population pharmacokinetics; Sample size; Sparse sampling; Volume of distribution

Indexed keywords

BISOPROLOL; CEFODIZIME; NIFEDIPINE;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG CLEARANCE; HUMAN; SAMPLE SIZE;

EID: 77950618922     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/DMDI.2009.24.2-4.259     Document Type: Article

References (7)

1. Duan J. Population pharmacokinetics. In: Mahmood I, ed. Clinical Pharmacology of Therapeutic Proteins. Rockville, MD: Pine House Publishers, 2006; 95-122.
2. www.rarediseases.info.nih.gov
3. www.eurordis.org
4. el Guinaidy MA, Nawishy S, Abd el Bary M, Sabbour MS. Pharmacokinetics of cefodizime in normal individuals and in patients with renal failure. Chemotherapy 1991; 37: 77-85.
5. Deroubaix X, Lins RL, Lens S, Demblon C, Jeanbaptiste B, Poelaert D, Stockis A. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers. Int J Clin Pharmacol Ther 1996; 34: 61-70. (Pubitemid 26053461)
6. Avgerinos A, Gorrod JW. Pharmacokinetics of nifedipine derived from a new retard tablet formulation. Eur J Drug Metab Pharmacokinet 1990; 15: 273-278.
7. Sheiner LB, Beal SL. Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data. J Pharmacokinet Biopharm 1980; 8: 553-571.